3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
103
Lymphoma
68
Lymphoma, Large B-Cell, Diffuse
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Sarcoma
33
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Leukemia
23
Burkitt Lymphoma
22
Neoplasms
19
Lymphoma, Mantle-Cell
18
Triple Negative Breast Neoplasms
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, B-Cell
14
Lymphoma, Large-Cell, Anaplastic
12
Carcinoma, Hepatocellular
12
Breast Neoplasms, Male
11
Neuroblastoma
10
Recurrence
9
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Inflammatory Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
8
Osteosarcoma
7
Fallopian Tube Neoplasms
7
Urinary Bladder Neoplasms
6
Liposarcoma
6
Interventions
Cisplatin
13
Radiotherapy, Intensity-Modulated
11
Radiotherapy
5
Carboplatin
5
Radiation
4
Cetuximab
4
durvalumab
3
Platinum
3
Nivolumab
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Specimen Handling
2
Restraint, Physical
2
Paclitaxel
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Bupropion
2
Biopsy
2
Acupuncture Therapy
2
veliparib
1
utomilumab
1
sodium thiosulfate
1
ficlatuzumab
1
dehydroftorafur
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oropharyngeal Neoplasms
×
Doxorubicin
×
Clear all
No trials found.